Natera vs Revolution Medicines
Natera (NTRA), health care, and Revolution Medicines (RVMD), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Natera is worth $41.7B on the stock market and Revolution Medicines $35.2B: Natera is valued at 18% more. Over the past year Natera's share price has moved +35.0% and Revolution Medicines's +136%.
Key facts
- Natera market value
- $41.7B
- Revolution Medicines market value
- $35.2B
- Natera revenue
- $2.3BFY to 2025-12-31
- Revolution Medicines revenue
- $0FY to 2025-12-31
- Superinvestors holding both
- 2
Market values as of .
| Measure | Natera | Revolution Medicines |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $41.7Bhigher | $35.2Blower |
| Revenue | $2.3Bhigher | $0lower |
| Earnings | -$208.2Mhigher | -$1.1Blower |
| Employees | 6,135higher | 883lower |
| Total assets | $2.4Bhigher | $2.4Blower |
| Valuation | ||
| P/E | — | — |
| P/S | 18.1 | — |
| P/B | 22.2higher | 14.7lower |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | -13.4% | — |
| Balance sheet | ||
| Net assets | $1.7Bhigher | $1.6Blower |
| Total liabilities | $685.9Mlower | $723.2Mhigher |
| Total debt | — | — |
| Cash on hand | $1.1Bhigher | $383.7Mlower |
| Price change | ||
| Today | -0.35%higher | -2.50%lower |
| 1 year | +35.0%lower | +136%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (2)
- Stanley Druckenmiller19.9% / 1.7%
- Andrew Spokes5.6% / 14.4%
Natera only (10)
- Lee Ainslie3.3%
- Philippe Laffont1.8%
- Cathie Wood1.3%
- Zach Schreiber1.2%
- Andreas Halvorsen0.3%
- Gavin Baker0.3%
- Cliff Asness0.2%
- David Shaw (founder)0.2%
- Paul Tudor Jones0.2%
- Temasek<0.1%
Revolution Medicines only (3)
- Julian and Felix Baker10.7%
- Brandon Haley0.6%
- Louis Bacon0.5%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Natera / Revolution Medicines). Who owns NTRA · Who owns RVMD
More on Natera
Further comparisons
Natera against its closest peers
Revolution Medicines against its closest peers
Learn
Questions and answers
Which is bigger, Natera or Revolution Medicines?
By market value, Natera is the larger: $41.7B against $35.2B for Revolution Medicines. By revenue in its latest fiscal year, Natera is the larger: $2.3B against $0 for Revolution Medicines.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both Natera and Revolution Medicines?
In their latest 13F filings, Stanley Druckenmiller and Andrew Spokes hold both.
Cite this page
Funkfolio, “Natera vs Revolution Medicines”, data as of 18 November 2026. https://funkfolio.com/compare/ntra-vs-rvmd
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.